In Vitro Activities of Several Diaminomethylpyridopyrimidines against Mycobacterium avium Complex
AUTOR(ES)
Shoen, Carolyn M.
FONTE
American Society for Microbiology
RESUMO
Three recently synthesized dihydrofolate reductase (DHFR) inhibitors designated SoRI 8890, 8895, and 8897 were evaluated for their in vitro activities against 25 isolates of Mycobacterium avium complex. The MICs at which 50 and 90% of isolates were inhibited were 1 and 2, 4 and 8, and 4 and 8 μg/ml for SoRI 8890, 8895, and 8897, respectively. Although the addition of dapsone at 0.5 μg/ml did not significantly enhance the in vitro activities of these compounds, their activities alone were comparable to, if not better than, results seen with other DHFR inhibitors, such as pyrimethamine or WR99210.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=106045Documentos Relacionados
- In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex.
- In vitro and in vivo activities of clarithromycin against Mycobacterium avium.
- Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages.
- In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis.
- Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex.